Nateglinide - CISMeF

Preferred Label : Nateglinide;

NCIt definition : A phenylalanine derivative of the meglitinide class of agents with hypoglycemic activity. Nateglinide, compared to repaglitinide, binds with a higher affinity to the SUR1 subunit and with a faster onset of action and a shorter duration of action. This agent is metabolized by the cytochrome P450 isoenzyme CYP2C9, and, to a lesser extent, by CYP3A4. The parent drug and metabolites are mainly excreted in the urine and its half-life is about 1.5 hours.;

UNII : 41X3PWK4O2;

InChIKey : OELFLUMRDSZNSF-BRWVUGGUSA-N;

CAS number : 105816-04-4;

Drug name : Starlix;

Chemical formula : C19H27NO3;

Détails

Origin ID

C61858;

UMLS CUI

C0903898;

Currated CISMeF NLP mapping
- Nateglinide [MeSH Descriptor]
- Nateglinide [ICD-11 Extension code]
- Nateglinide [LOINC component]
- Nateglinide (substance) [SNOMED CT concept]
- nateglinide [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nateglinide [MeSH Descriptor]
- Nateglinide [LOINC component]
- Nateglinide (substance) [SNOMED CT concept]
- Product containing nateglinide (medicinal product) [SNOMED CT concept]
- nateglinide [ATC Code]
- nateglinide [MeSH concept]
Validated automatic mappings to BTNT
- nateglinide [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients